NSAID labelling appropriate
September 29, 2011
OVER the counter non-steroidal
anti-inflammatory drugs (NSAID)
taken in low doses for short
periods of time do not increase the
risk of cardiovascular events, a
new study published in PLoS
Medicine has found.
These results, according to the
Australian Self-Medication
Industry, reaffirm the current
labelling of various NSAID products
in Australia.
“While there are some
limitations to the study, including
its reliance on observational
studies, it does shine a light on
some risks associated with these
products, and in particular the
relationship between higher doses
and increased risk,” said ASMI
Regulatory and Scientific Affairs
Director, Steven Scarff.
Findings in the study included
that both ibuprofen and naproxen
did not increase cardiovascular risk
when used in low doses for short
periods.
The study did however find that
prescription doses of Diclofenac
were associated with an increased
cardiovascular risk.
“Diclofenac is a common antiinflammatory
medicine and has
been in use for many years,” said
Scarff.
“Anyone who is in a high risk
category such as people with heart
problems should, as with any
medication, consult their GP or
pharmacist before using any
medicines,” he added.
In light of the findings ASMI also
reminded Australians to always
take note of label warnings and to
strictly follow all the directions.
The above article was sent to subscribers in Pharmacy Daily's issue from 29 Sep 11To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Sep 11
Warning: Undefined variable $flipbook_id in
/home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line
1259
Warning: Undefined variable $o_shortcode_atts in
/home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line
1263
Warning: Undefined variable $output in
/home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line
1266
